Scarica l'app Stockscreener
1.19
4.80%
-0.06
Dopo l'orario di chiusura:
1.19
Precedente Chiudi:
$1.25
Aprire:
$1.24
Volume 24 ore:
683.23K
Relative Volume:
3.35
Capitalizzazione di mercato:
$43.61M
Reddito:
-
Utile/perdita netta:
$-9.16M
Rapporto P/E:
-2.0877
EPS:
-0.57
Flusso di cassa netto:
$-8.75M
1 W Prestazione:
+25.58%
1M Prestazione:
-1.65%
6M Prestazione:
+26.50%
1 anno Prestazione:
+17.82%
Intervallo 1D:
$1.16
$1.26
Intervallo di 1 settimana:
$0.94
$1.26
Portata 52W:
$0.75
$1.6899
Renovorx Inc Stock (RNXT) Company Profile
Nome
Renovorx Inc
Settore
Industria
Telefono
408-800-2649
Indirizzo
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW
Confronta RNXT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RNXT
Renovorx Inc
|
1.19 | 39.58M | 0 | -9.16M | -8.75M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovorx Inc Borsa (RNXT) Ultime notizie
Leading vs lagging indicators on RenovoRx Inc. performance2025 Market Outlook & Low Drawdown Momentum Trade Ideas - Newser
Can RenovoRx Inc. recover in the next quarterQuarterly Portfolio Summary & Daily Entry Point Alerts - Newser
How moving averages guide RenovoRx Inc. tradingTrade Exit Summary & Verified Short-Term Plans - Newser
Will breakout in RenovoRx Inc. lead to full recoveryJuly 2025 Action & Expert Curated Trade Setups - Newser
Sector ETF performance correlation with RenovoRx Inc.July 2025 Highlights & Reliable Breakout Forecasts - Newser
What hedge funds are buying RenovoRx Inc.2025 Technical Patterns & Daily Volume Surge Trade Alerts - khodrobank.com
RenovoRx Inc. stock prediction for this week2025 Market WrapUp & Weekly High Return Stock Forecasts - Newser
Is RenovoRx Inc. showing signs of accumulationJuly 2025 EndofMonth & Safe Entry Trade Reports - Newser
How high can RenovoRx Inc. stock go2025 Market Overview & Weekly Market Pulse Updates - Newser
Key metrics from RenovoRx Inc.’s quarterly dataMarket Activity Summary & Consistent Profit Focused Trading Strategies - Newser
Can volume confirm reversal in RenovoRx Inc.Quarterly Profit Review & Technical Pattern Based Signals - Newser
Using RSI to spot recovery in RenovoRx Inc.Weekly Market Report & AI Powered Buy and Sell Recommendations - Newser
How RenovoRx Inc. stock performs during market volatilityTrade Ideas & Precise Buy Zone Tips - Newser
RenovoRx : Corporate Overview - MarketScreener
Can RenovoRx Inc. disrupt its industryStop Loss & Consistent Income Trade Recommendations - khodrobank.com
What institutional flow reveals about RenovoRx Inc.Portfolio Return Report & Low Drawdown Trading Strategies - Newser
What recovery options are there for RenovoRx Inc.Trade Analysis Summary & Weekly Stock Breakout Alerts - Newser
RenovoRx Inc. recovery potential after sell offEarnings Recap Report & Advanced Swing Trade Entry Alerts - Newser
What’s the recovery path for long term holders of RenovoRx Inc.Portfolio Return Summary & AI Driven Stock Reports - Newser
What analysts say about RenovoRx Inc. stockOil Prices & Weekly Setup with High ROI Potential - khodrobank.com
RenovoRx's Q2 Earnings Call Highlights Strong Sales and Positive Outlook Amid Growth. - AInvest
What drives RenovoRx Inc.’s stock priceJuly 2025 Catalysts & Consistent Profit Trade Alerts - khodrobank.com
Does RenovoRx Inc. outperform in volatile markets2025 Performance Recap & Stepwise Trade Signal Implementation - khodrobank.com
RenovoRx Revenue Jumps 28 Percent in Q2 - AOL.com
RenovoRx’s Earnings Call: Positive Outlook Amid Growth - TipRanks
Using flow based indicators on RenovoRx Inc.2025 Retail Activity & High Accuracy Swing Entry Alerts - Newser
Tools to monitor RenovoRx Inc. recovery probabilityBreakout Watch & Free Growth Oriented Trading Recommendations - Newser
Published on: 2025-08-31 13:19:16 - Newser
Analyzing recovery setups for RenovoRx Inc. investorsJuly 2025 Pullbacks & Daily Market Momentum Tracking - Newser
RenovoRx Inc. stock momentum explainedWeekly Trend Summary & Verified Momentum Stock Ideas - Newser
Is RenovoRx Inc. meeting your algorithmic filter criteriaPortfolio Value Summary & Growth Focused Stock Pick Reports - Newser
Signal strength of RenovoRx Inc. stock in tech scannersPrice Action & Stock Market Timing Techniques - Newser
Pattern Scan Adds RenovoRx Inc. to Watchlist getLinesFromResByArray error: size == 0 - 더경남뉴스
Is RenovoRx Inc. stock bottoming outNew Guidance & Safe Entry Point Identification - Newser
Will RenovoRx Inc. stock recover after recent dropQuarterly Trade Summary & Daily Price Action Insights - Newser
Renovorx Inc Azioni (RNXT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Renovorx Inc Azioni (RNXT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bagai Shaun | Chief Executive Officer |
Aug 25 '25 |
Buy |
0.91 |
5,000 |
4,549 |
330,040 |
| Agah Ramtin | Chief Medical Officer |
Jun 05 '25 |
Buy |
1.40 |
21,000 |
29,400 |
734,460 |
| Marton Laurence | Director |
May 02 '25 |
Option Exercise |
0.15 |
20,480 |
3,072 |
66,164 |
| Agah Ramtin | Chief Medical Officer |
Apr 15 '25 |
Buy |
0.90 |
15,000 |
13,500 |
1,113,460 |
| Bagai Shaun | Chief Executive Officer |
Apr 15 '25 |
Buy |
0.91 |
7,500 |
6,821 |
320,040 |
| Agah Ramtin | Chief Medical Officer |
Apr 11 '25 |
Buy |
0.80 |
20,000 |
16,000 |
1,098,460 |
| Kocak Ron | VP Controller and PAO |
Apr 10 '25 |
Buy |
0.79 |
6,500 |
5,135 |
12,595 |
| Kocak Ron | VP Controller and PAO |
Apr 09 '25 |
Buy |
0.80 |
6,000 |
4,800 |
6,095 |
| Kocak Ron | VP Controller and PAO |
Apr 08 '25 |
Buy |
0.80 |
95 |
76 |
95 |
| Agah Ramtin | Chief Medical Officer |
Apr 09 '25 |
Buy |
0.81 |
30,000 |
24,399 |
1,078,460 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):